SpliceBio Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 45

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $135M

  • Investors
  • 11

SpliceBio General Information

Description

Operator of a biotechnology company intended to develop genetic medicines through protein-splicing gene therapy. The company's platform allows addressing of adeno-associated viruses, both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted and further used to treat patients that suffer from incurable genetic diseases, enabling clients to develop and produce biotherapeutics that overcome the limitations of natural inteins.

Contact Information

Website
www.splice.bio
Formerly Known As
ProteoDesign
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • C Baldiri i Reixac, número 10-12
  • Parc Científic de Barcelona
  • 08028 Barcelona
  • Spain
+34 934
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • C Baldiri i Reixac, número 10-12
  • Parc Científic de Barcelona
  • 08028 Barcelona
  • Spain
+34 934

SpliceBio Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SpliceBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series B) 11-Jun-2025 $135M Completed Generating Revenue
8. Secondary Transaction - Private Completed Generating Revenue
7. Later Stage VC (Series A) 16-Feb-2022 Completed Generating Revenue
6. Grant 10-Dec-2020 Completed Pre-Clinical Trials
5. Seed Round 22-Jun-2020 Completed Pre-Clinical Trials
4. Early Stage VC 12-Dec-2017 Completed Pre-Clinical Trials
3. Seed Round 20-Apr-2015 Completed Pre-Clinical Trials
2. Seed Round 13-Dec-2014 Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2012 Completed Startup
To view SpliceBio’s complete valuation and funding history, request access »

SpliceBio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 44,243 $1.118140 $16.76 $16.76 1x $16.76 8.79%
To view SpliceBio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

SpliceBio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to develop genetic medicines through protein-splicing gene therapy. The com
Drug Discovery
Barcelona, Spain
45 As of 2025

Pampisford, United Kingdom
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SpliceBio Competitors (95)

One of SpliceBio’s 95 competitors is PhoreMost, a Venture Capital-Backed company based in Pampisford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PhoreMost Venture Capital-Backed Pampisford, United Kingdom
Neuron23 Venture Capital-Backed South San Francisco, CA
Healx Venture Capital-Backed Cambridge, United Kingdom
Stoke Therapeutics Formerly VC-backed Bedford, MA
PAQ Therapeutics Venture Capital-Backed Cambridge, MA
You’re viewing 5 of 95 competitors. Get the full list »

SpliceBio Patents

SpliceBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021241899-A1 Split inteins and their uses Pending 26-Mar-2020
CA-3175696-A1 Split inteins and their uses Pending 26-Mar-2020
EP-3885440-A1 Split inteins and their uses Pending 26-Mar-2020
EP-4127194-A1 Split inteins and their uses Pending 26-Mar-2020
US-20230116688-A1 Split inteins and their uses Pending 26-Mar-2020 C12N15/86
To view SpliceBio’s complete patent history, request access »

SpliceBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SpliceBio Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
EQT Life Sciences Venture Capital Minority
Roche Corporation Minority
Sanofi Ventures Corporate Venture Capital Minority
Gilde Healthcare Venture Capital Minority
New Enterprise Associates Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

SpliceBio FAQs

  • When was SpliceBio founded?

    SpliceBio was founded in 2012.

  • Where is SpliceBio headquartered?

    SpliceBio is headquartered in Barcelona, Spain.

  • What is the size of SpliceBio?

    SpliceBio has 45 total employees.

  • What industry is SpliceBio in?

    SpliceBio’s primary industry is Drug Discovery.

  • Is SpliceBio a private or public company?

    SpliceBio is a Private company.

  • What is SpliceBio’s current revenue?

    The current revenue for SpliceBio is .

  • How much funding has SpliceBio raised over time?

    SpliceBio has raised $198M.

  • Who are SpliceBio’s investors?

    EQT Life Sciences, Roche, Sanofi Ventures, Gilde Healthcare, and New Enterprise Associates are 5 of 11 investors who have invested in SpliceBio.

  • Who are SpliceBio’s competitors?

    PhoreMost, Neuron23, Healx, Stoke Therapeutics, and PAQ Therapeutics are some of the 95 competitors of SpliceBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »